15-48226575-A-T

Variant summary

Our verdict is Uncertain significance. The variant received 1 ACMG points: 2P and 1B. PM2BP4

The NM_000338.3(SLC12A1):​c.724+4A>T variant causes a splice region, intron change involving the alteration of a conserved nucleotide. The variant allele was found at a frequency of 0.000000697 in 1,434,550 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a benign outcome for this variant. 3/3 splice prediction tools predict no significant impact on normal splicing. No clinical diagnostic laboratories have submitted clinical-significance assessments for this variant to ClinVar.

Frequency

Genomes: not found (cov: 32)
Exomes 𝑓: 7.0e-7 ( 0 hom. )

Consequence

SLC12A1
NM_000338.3 splice_region, intron

Scores

1
2
Splicing: ADA: 0.6744
2

Clinical Significance

Not reported in ClinVar

Conservation

PhyloP100: 7.53

Publications

2 publications found
Variant links:
Genes affected
SLC12A1 (HGNC:10910): (solute carrier family 12 member 1) This gene encodes a kidney-specific sodium-potassium-chloride cotransporter that is expressed on the luminal membrane of renal epithelial cells of the thick ascending limb of Henle's loop and the macula densa. It plays a key role in concentrating urine and accounts for most of the NaCl resorption. It is sensitive to such diuretics as furosemide and bumetanide. Some Bartter-like syndromes result from defects in this gene. Alternative splicing results in multiple transcript variants encoding distinct isoforms. Additional splice variants have been described but their biological validity in humans has not been experimentally proven.[provided by RefSeq, May 2010]
SLC12A1 Gene-Disease associations (from GenCC):
  • antenatal Bartter syndrome
    Inheritance: AR Classification: DEFINITIVE, SUPPORTIVE Submitted by: ClinGen, Orphanet
  • Bartter disease type 1
    Inheritance: AR Classification: STRONG Submitted by: PanelApp Australia, Labcorp Genetics (formerly Invitae)

Genome browser will be placed here

new If you want to explore the variant's impact on the transcript NM_000338.3, check out the Mutation Effect Viewer. This is especially useful for frameshift variants or if you want to visualize the effect of exon loss / intron retention.

ACMG classification

Classification was made for transcript

Our verdict: Uncertain_significance. The variant received 1 ACMG points.

PM2
Very rare variant in population databases, with high coverage;
BP4
Computational evidence support a benign effect (BayesDel_noAF=-0.18).

Variant Effect in Transcripts

ACMG analysis was done for transcript: NM_000338.3. You can select a different transcript below to see updated ACMG assignments.

RefSeq Transcripts

Sel.
GeneTranscriptTagsHGVScHGVSpEffectExon RankProteinUniProt
SLC12A1
NM_000338.3
MANE Select
c.724+4A>T
splice_region intron
N/ANP_000329.2Q13621-1
SLC12A1
NM_001184832.2
c.629-504A>T
intron
N/ANP_001171761.1Q13621-3
SLC12A1
NM_001384136.1
c.724+628A>T
intron
N/ANP_001371065.1A0A8I5KSK6

Ensembl Transcripts

Sel.
GeneTranscriptTagsHGVScHGVSpEffectExon RankProteinUniProt
SLC12A1
ENST00000380993.8
TSL:5 MANE Select
c.724+4A>T
splice_region intron
N/AENSP00000370381.3Q13621-1
SLC12A1
ENST00000330289.10
TSL:1
c.724+4A>T
splice_region intron
N/AENSP00000331550.6Q8IUN5
SLC12A1
ENST00000558252.5
TSL:1
n.4248A>T
non_coding_transcript_exon
Exon 1 of 23

Frequencies

GnomAD3 genomes
Cov.:
32
GnomAD2 exomes
AF:
0.00000409
AC:
1
AN:
244754
AF XY:
0.00000753
show subpopulations
Gnomad AFR exome
AF:
0.00
Gnomad AMR exome
AF:
0.00
Gnomad ASJ exome
AF:
0.00
Gnomad EAS exome
AF:
0.00
Gnomad FIN exome
AF:
0.00
Gnomad NFE exome
AF:
0.00000898
Gnomad OTH exome
AF:
0.00
GnomAD4 exome
AF:
6.97e-7
AC:
1
AN:
1434550
Hom.:
0
Cov.:
25
AF XY:
0.00
AC XY:
0
AN XY:
715124
show subpopulations
African (AFR)
AF:
0.00
AC:
0
AN:
32734
American (AMR)
AF:
0.00
AC:
0
AN:
44098
Ashkenazi Jewish (ASJ)
AF:
0.00
AC:
0
AN:
25968
East Asian (EAS)
AF:
0.00
AC:
0
AN:
39410
South Asian (SAS)
AF:
0.00
AC:
0
AN:
84464
European-Finnish (FIN)
AF:
0.0000187
AC:
1
AN:
53350
Middle Eastern (MID)
AF:
0.00
AC:
0
AN:
5720
European-Non Finnish (NFE)
AF:
0.00
AC:
0
AN:
1089306
Other (OTH)
AF:
0.00
AC:
0
AN:
59500
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.425
Heterozygous variant carriers
0
0
1
1
2
2
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance
GnomAD4 genome
Cov.:
32
Alfa
AF:
0.00
Hom.:
0
Bravo
AF:
0.00000378

ClinVar

Not reported in ClinVar

Computational scores

Source: dbNSFP v4.9

Name
Calibrated prediction
Score
Prediction
BayesDel_noAF
Benign
-0.18
CADD
Benign
22
DANN
Uncertain
0.98
PhyloP100
7.5

Splicing

Name
Calibrated prediction
Score
Prediction
dbscSNV1_ADA
Benign
0.67
dbscSNV1_RF
Benign
0.66
SpliceAI score (max)
0.13
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

MaxEntScan Visualizer can be used to analyze the impact of this mutation on the neighboring sequence.

Publications

Other links and lift over

dbSNP: rs774515747;
hg19: chr15-48518772;
For research and educational, non-commercial use only. Not for clinical or diagnostic use. GeneBe does not provide medical advice. Data use for AI modeling is prohibited: if used, the cost is $0.001 per byte of downloaded uncompressed data.